country	study_id	serotracker_id_short	age_low	age_high	region	gender	n_tested	n_positive	seroprevalence_unadjusted	range_sero_low	range_sero_high	seroprevalence_weighted	matching_deaths_data	date_start_survey	date_end_survey	age_breakdown	gender_breakdown	for_regional_analysis	basic_summary	ref	notes	Column1
Brazil	BRA1		0	4	all	both	430		0.014	0.005	0.03		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		5	9	all	both	682		0.012	0.005	0.023		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		10	19	all	both	2287		0.014	0.009	0.019		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		20	29	all	both	3866		0.014	0.011	0.018		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		30	39	all	both	3834		0.015	0.012	0.02		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		40	49	all	both	3975		0.016	0.012	0.02		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		50	59	all	both	4015		0.017	0.013	0.021		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		60	69	all	both	3381		0.01	0.007	0.014		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		70	79	all	both	1797		0.012	0.008	0.018		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		80	999	all	both	728		0.005	0.001	0.014		brazil.RDS	2020-05-15	2020-05-22	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf		
Brazil	BRA1		0	999	Central-West	both	2477	0	0				brazil.RDS	2020-05-15	2020-05-22	0	0	1	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf	Cities with unknown raw positive counts were dropped (n=7)	
Brazil	BRA1		0	999	North	both	4710	269	0.05711252654				brazil.RDS	2020-05-15	2020-05-22	0	0	1	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf	Cities with unknown raw positive counts were dropped (n=7)	
Brazil	BRA1		0	999	Northeast	both	6023	38	0.006309148265				brazil.RDS	2020-05-15	2020-05-22	0	0	1	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf	Cities with unknown raw positive counts were dropped (n=7)	
Brazil	BRA1		0	999	South	both	5309	9	0.001695234507				brazil.RDS	2020-05-15	2020-05-22	0	0	1	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf	Cities with unknown raw positive counts were dropped (n=7)	
Brazil	BRA1		0	999	Southeast	both	5682	21	0.003695881732				brazil.RDS	2020-05-15	2020-05-22	0	0	1	0	https://www.medrxiv.org/content/10.1101/2020.05.30.20117531v1.full.pdf	Cities with unknown raw positive counts were dropped (n=7)	
Switzerland	CHE1		5	999	Geneva	Female	179	2	0.01117318436				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Female	243	15	0.06172839506				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Female	307	29	0.09446254072				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Female	305	18	0.05901639344				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Female	400	37	0.0925				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Male	155	10	0.06451612903				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Male	220	13	0.05909090909				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Male	254	32	0.125984252				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Male	288	18	0.0625				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	Male	367	45	0.1226158038				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	0	1	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	both	334	12	0.03592814371				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	0	0	1	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	both	463	28	0.06047516199				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	0	0	1	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	both	561	61	0.1087344029				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	0	0	1	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	both	593	36	0.06070826307				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	0	0	1	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	999	Geneva	both	767	82	0.1069100391				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	0	0	1	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	9	Geneva	both	16	0	0				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	9	Geneva	both	15	0	0				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	9	Geneva	both	21	1	0.04761904762				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	9	Geneva	both	26	0	0				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		5	9	Geneva	both	37	0	0				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		10	19	Geneva	both	43	0	0				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		10	19	Geneva	both	54	4	0.07407407407				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		10	19	Geneva	both	68	10	0.1470588235				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		10	19	Geneva	both	74	5	0.06756756757				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		10	19	Geneva	both	88	13	0.1477272727				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		20	49	Geneva	both	146	7	0.04794520548				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		20	49	Geneva	both	191	16	0.08376963351				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		20	49	Geneva	both	222	32	0.1441441441				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		20	49	Geneva	both	221	19	0.08597285068				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		20	49	Geneva	both	298	34	0.1140939597				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		50	64	Geneva	both	97	5	0.05154639175				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		50	64	Geneva	both	137	6	0.04379562044				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		50	64	Geneva	both	179	14	0.0782122905				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		50	64	Geneva	both	187	11	0.05882352941				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		50	64	Geneva	both	235	27	0.114893617				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		65	999	Geneva	both	32	0	0				CHE1_death_timeseries.RDS	2020-04-06	2020-04-13	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		65	999	Geneva	both	66	2	0.0303030303				CHE1_death_timeseries.RDS	2020-04-13	2020-04-20	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		65	999	Geneva	both	71	4	0.05633802817				CHE1_death_timeseries.RDS	2020-04-20	2020-04-27	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		65	999	Geneva	both	85	1	0.01176470588				CHE1_death_timeseries.RDS	2020-04-27	2020-05-03	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Switzerland	CHE1		65	999	Geneva	both	109	8	0.07339449541				CHE1_death_timeseries.RDS	2020-05-03	2020-05-10	1	0	0	0	https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(20)31304-0/fulltext	Contacted study authors for additional data details	
Denmark	DNK1		17	29	all	both	5068	125	0.02466456196				deaths.csv	2020-04-06	2020-05-03	1	0	0	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		30	39	all	both	4039	56	0.01386481802				deaths.csv	2020-04-06	2020-05-03	1	0	0	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		40	49	all	both	4841	99	0.02045032018				deaths.csv	2020-04-06	2020-05-03	1	0	0	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		50	59	all	both	4501	77	0.01710730949				deaths.csv	2020-04-06	2020-05-03	1	0	0	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		60	69	all	both	2191	55	0.02510269283				deaths.csv	2020-04-06	2020-05-03	1	0	0	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		17	69	all	Male	10217	213	0.02084760693				deaths.csv	2020-04-06	2020-05-03	0	1	0	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		17	69	all	Female	10423	199	0.01909239183				deaths.csv	2020-04-06	2020-05-03	0	1	0	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		17	69	Capital	both	6528	203	0.03109681373				deaths.csv	2020-04-06	2020-05-03	0	0	1	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		17	69	Central DK & North DK	both	6226	79	0.0126887247				deaths.csv	2020-04-06	2020-05-03	0	0	1	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Denmark	DNK1		17	69	South DK & Zealand	both	7886	130	0.01648490997				deaths.csv	2020-04-06	2020-05-03	0	0	1	0	https://academic.oup.com/cid/article/doi/10.1093/cid/ciaa849/5862661		
Spain	ESP1-2		0	0	all	 both	268		0.011	0.003000	0.038		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2020		
Spain	ESP1-2		1	4	all	 both	1693		0.022000	0.014	0.036		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2021		
Spain	ESP1-2		5	9	all	 both	2857		0.030000	0.023	0.041		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2022		
Spain	ESP1-2		10	14	all	 both	3425		0.039000	0.031	0.049		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2023		
Spain	ESP1-2		15	19	all	 both	3221		0.038000	0.03	0.049		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2024		
Spain	ESP1-2		20	24	all	 both	2805		0.045000	0.035	0.057		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2025		
Spain	ESP1-2		25	29	all	 both	2606		0.048000	0.037	0.061		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2026		
Spain	ESP1-2		30	34	all	 both	3050		0.038000	0.029	0.049		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2027		
Spain	ESP1-2		35	39	all	 both	4000		0.046000	0.038	0.056		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2028		
Spain	ESP1-2		40	44	all	 both	5174		0.053000	0.045	0.062		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2029		
Spain	ESP1-2		45	49	all	 both	5330		0.057000	0.049	0.067		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2030		
Spain	ESP1-2		50	54	all	 both	5263		0.058000	0.049	0.069		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2031		
Spain	ESP1-2		55	59	all	 both	5187		0.061000	0.052	0.072		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2032		
Spain	ESP1-2		60	64	all	 both	4560		0.059000	0.05	0.07		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2033		
Spain	ESP1-2		65	69	all	 both	3568		0.062000	0.051	0.074		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2034		
Spain	ESP1-2		70	74	all	 both	2931		0.069000	0.057	0.083		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2035		
Spain	ESP1-2		75	79	all	 both	2161		0.061000	0.048	0.077		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2036		
Spain	ESP1-2		80	84	all	 both	1410		0.051000	0.038	0.069		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2037		
Spain	ESP1-2		85	89	all	 both	968		0.056000	0.038	0.082		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2038		
Spain	ESP1-2		90	999	all	 both	420		0.058	0.032000	0.1		deaths.csv	2020-04-27	2020-05-11	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2039		
Spain	ESP1-2		0	999	all	male	29255		0.05	0.046	0.054		deaths.csv	2020-04-27	2020-05-11	0	1	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2040		
Spain	ESP1-2		0	999	all	female	31642		0.051	0.047	0.055		deaths.csv	2020-04-27	2020-05-11	0	1	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2041		
Spain	ESP1-2		0	999	Andalucía	both	9726		0.027	0.022	0.032000		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2042		
Spain	ESP1-2		0	999	Aragón	both	2748		0.049	0.038000	0.063		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2043		
Spain	ESP1-2		0	999	Asturias, Principado de	both	1545		0.018	0.013000	0.025		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2044		
Spain	ESP1-2		0	999	Balears, Illes	both	1356		0.024	0.016000	0.035		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2045		
Spain	ESP1-2		0	999	Canarias	both	2324		0.018	0.011000	0.028		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2046		
Spain	ESP1-2		0	999	Cantabria	both	1504		0.032	0.021000	0.05		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2047		
Spain	ESP1-2		0	999	Castilla y León	both	6949		0.072	0.063000	0.081		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2048		
Spain	ESP1-2		0	999	Castilla La Mancha	both	5066		0.108000	0.093	0.124		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2049		
Spain	ESP1-2		0	999	Cataluña	both	6318		0.059	0.049000	0.069		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2050		
Spain	ESP1-2		0	999	Comunitat Valenciana	both	4286		0.025	0.019000	0.032		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2051		
Spain	ESP1-2		0	999	Extremadura	both	2787		0.03	0.022000	0.041		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2052		
Spain	ESP1-2		0	999	Galicia	both	4070		0.021	0.017000	0.026		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2053		
Spain	ESP1-2		0	999	Madrid, Comunidad de	both	3185		0.113	0.098000	0.13		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2054		
Spain	ESP1-2		0	999	Murcia, Región de	both	1387		0.014	0.008000	0.024		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2055		
Spain	ESP1-2		0	999	Navarra, Comunidad Foral de	both	1737		0.058	0.043000	0.076		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2056		
Spain	ESP1-2		0	999	País Vasco	both	2830		0.04	0.031000	0.052		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2057		
Spain	ESP1-2		0	999	Rioja, La	both	1323		0.033	0.024000	0.044		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2058		
Spain	ESP1-2		0	999	Ceuta	both	829		0.011	0.005000	0.023		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2059		
Spain	ESP1-2		0	999	Melilla	both	927		0.019	0.012000	0.029		deaths.csv	2020-04-27	2020-05-11	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_PRIMERA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 22, 2060		
Spain	ESP1-2		0	0	all	both	263		0.022	0.007	0.068			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2020		
Spain	ESP1-2		1	4	all	both	1679		0.024	0.015	0.038			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2021		
Spain	ESP1-2		5	9	all	both	2896		0.029	0.022	0.04			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2022		
Spain	ESP1-2		10	14	all	both	3549		0.038	0.03	0.048			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2023		
Spain	ESP1-2		15	19	all	both	3343		0.038	0.03	0.048			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2024		
Spain	ESP1-2		20	24	all	both	2916		0.042	0.032	0.054			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2025		
Spain	ESP1-2		25	29	all	both	2683		0.049	0.038	0.063			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2026		
Spain	ESP1-2		30	34	all	both	3182		0.044	0.034	0.056			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2027		
Spain	ESP1-2		35	39	all	both	4148		0.047	0.038	0.057			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2028		
Spain	ESP1-2		40	44	all	both	5422		0.054	0.046	0.063			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2029		
Spain	ESP1-2		45	49	all	both	5611		0.059	0.051	0.069			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2030		
Spain	ESP1-2		50	54	all	both	5529		0.061	0.053	0.07			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2031		
Spain	ESP1-2		55	59	all	both	5411		0.057	0.049	0.067			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2032		
Spain	ESP1-2		60	64	all	both	4817		0.063	0.053	0.073			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2033		
Spain	ESP1-2		65	69	all	both	3755		0.066	0.056	0.078			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2034		
Spain	ESP1-2		70	74	all	both	3137		0.073	0.061	0.087			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2035		
Spain	ESP1-2		75	79	all	both	2283		0.064	0.051	0.08			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2036		
Spain	ESP1-2		80	84	all	both	1479		0.051	0.038	0.067			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2037		
Spain	ESP1-2		85	89	all	both	1005		0.064	0.044	0.09			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2038		
Spain	ESP1-2		90	999	all	both	456		0.08	0.05	0.126			2020-05-18	2020-06-01	1	0	0	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2039		
Spain	ESP1-2		0	999	Andalucía	both	9801		0.029	0.025	0.034			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2040		
Spain	ESP1-2		0	999	Aragón	both	2678		0.049	0.039	0.063			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2041		
Spain	ESP1-2		0	999	Asturias, Principado de	both	1711		0.016	0.011	0.023			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2042		
Spain	ESP1-2		0	999	Balears, Illes	both	1327		0.015	0.009	0.025			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2043		
Spain	ESP1-2		0	999	Canarias	both	2691		0.027	0.017	0.043			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2044		
Spain	ESP1-2		0	999	Cantabria	both	1660		0.032	0.021	0.047			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2045		
Spain	ESP1-2		0	999	Castilla y León	both	7312		0.075	0.065	0.086			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2046		
Spain	ESP1-2		0	999	Castilla La Mancha	both	5177		0.103	0.087	0.122			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2047		
Spain	ESP1-2		0	999	Cataluña	both	6616		0.061	0.052	0.072			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2048		
Spain	ESP1-2		0	999	Comunitat Valenciana	both	4538		0.027	0.022	0.034			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2049		
Spain	ESP1-2		0	999	Extremadura	both	2790		0.033	0.024	0.044			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2050		
Spain	ESP1-2		0	999	Galicia	both	3998		0.022	0.017	0.028			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2051		
Spain	ESP1-2		0	999	Madrid, Comunidad de	both	3703		0.114	0.1	0.13			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2052		
Spain	ESP1-2		0	999	Murcia, Región de	both	1582		0.016	0.011	0.025			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2053		
Spain	ESP1-2		0	999	Navarra, Comunidad Foral de	both	1755		0.064	0.049	0.083			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2054		
Spain	ESP1-2		0	999	País Vasco	both	2995		0.037	0.028	0.049			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2055		
Spain	ESP1-2		0	999	Rioja, La	both	1401		0.039	0.028	0.053			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2056		
Spain	ESP1-2		0	999	Ceuta	both	904		0.005	0.001	0.017			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2057		
Spain	ESP1-2		0	999	Melilla	both	925		0.032	0.022	0.046			2020-05-18	2020-06-01	0	0	1	0	https://www.mscbs.gob.es/ciudadanos/ene-covid/docs/ESTUDIO_ENE-COVID19_SEGUNDA_RONDA_INFORME_PRELIMINAR.pdf, accessed July 20, 2058		
United Kingdom	GBR1		18	75	Scotland	both	500	0	0					2020-03-17	2020-03-17	0	0	0	1	https://www.medrxiv.org/content/10.1101/2020.04.13.20060467v1	blood donors. assay is for 'neutralizing antibodies' (unusual)	
United Kingdom	GBR1		18	75	Scotland	both	500	5	0.01					2020-03-21	2020-03-23	0	0	0	1	https://www.medrxiv.org/content/10.1101/2020.04.13.20060467v1	blood donors. assay is for 'neutralizing antibodies' (unusual)	
USA	LA_CA1		18	999	Los Angeles County, California	both	863	35	0.0406			0.0431		2020-10-04	2020-11-04	0	0	1	0	https://jamanetwork.com/journals/jama/fullarticle/2766367		
Netherlands	NLD1		18	30	all	both	1251	52	0.041566747				deaths.csv	2020-04-01	2020-04-15	1	0	0	0	https://www.researchsquare.com/article/rs-25862/v1		
Netherlands	NLD1		31	40	all	both	882	22	0.024943311				deaths.csv	2020-04-01	2020-04-15	1	0	0	0	https://www.researchsquare.com/article/rs-25862/v1		
Netherlands	NLD1		41	50	all	both	1354	31	0.022895126				deaths.csv	2020-04-01	2020-04-15	1	0	0	0	https://www.researchsquare.com/article/rs-25862/v1		
Netherlands	NLD1		51	60	all	both	2132	48	0.022514071				deaths.csv	2020-04-01	2020-04-15	1	0	0	0	https://www.researchsquare.com/article/rs-25862/v1		
Netherlands	NLD1		60	72	all	both	1742	47	0.026980482				deaths.csv	2020-04-01	2020-04-15	1	0	0	0	https://www.researchsquare.com/article/rs-25862/v1		
Netherlands	NLD1		18	72	Amsterdam-Amstelland	both				0.03	0.04		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Brabant-Noord	both				NA	NA		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Brabant-Zuidoost	both				0.09	0.1		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus	no sample sizes by region contact authors?	
Netherlands	NLD1		18	72	Drenthe	both				0	0.01		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Flevoland	both				0	0		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Fryslan	both				0	0.01		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Gelderland-Midden	both				0	0.01		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Gelderland-Zuid	both				0.03	0.04		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Gooi en Vechtstreek	both				0	0		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Groningen	both				0.01	0.02		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Haaglanden	both				0.01	0.02		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Hollands Midden	both				0.01	0.02		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	IJsselland	both				0.01	0.02		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Kennemerland	both				0.02	0.03		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Limburg-Noord	both				0.06	0.07		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Midden- en West-Brabant	both				NA	NA		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus	boundaries not the same as regional map	
Netherlands	NLD1		18	72	Noord- en Oost-Gelderland	both				0.02	0.03		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Noord-Holland-Noord	both				0.02	0.03		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Rotterdam-Rijnmond	both				0	0.01		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Twente	both				0.03	0.04		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Utrecht	both				NA	NA		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus	boundaries not the same as regional map (contains a city in the middle)	
Netherlands	NLD1		18	72	Zaanstreek-Waterland	both				0.01	0.02		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Zeeland	both				0.01	0.02		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Zuid-Holland-Zuid	both				0.01	0.02		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus		
Netherlands	NLD1		18	72	Zuid-Limburg	both				0.03	0.04		deaths.csv	2020-04-01	2020-04-15	0	0	1	0	https://www.researchsquare.com/article/rs-25862/v1, updated maps on https://www.sanquin.nl/over-sanquin/persberichten/2020/06/sanquin-rapporteert-regionale-seroprevalentie-coronavirus	seroprevalence given to nearest 1%, so this is the lower bound, add 0.01 for the higher bound	
Sweden	SWE1		0	19	J‰mtland, Jˆnkˆping, Kalmar, SkÂne, Stockholm, Uppsala, V‰sterbotten, V‰stra Gˆtaland and ÷rebro	both			0.047				deaths.csv	2020-04-27	2020-05-03	1	0	0	0	https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-for-covid-19-virus/ , accessed 31/05/2020	Blood samples are collected from laboratories in clinical chemistry and clinical immunology in nine regions. 1104 samples total. These 9 regions include 7180898 out of Sweden's total population of 10327589	
Sweden	SWE1		20	64	J‰mtland, Jˆnkˆping, Kalmar, SkÂne, Stockholm, Uppsala, V‰sterbotten, V‰stra Gˆtaland and ÷rebro	both			0.067				deaths.csv	2020-04-27	2020-05-03	1	0	0	0	https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-for-covid-19-virus/ , accessed 31/05/2020	Blood samples are collected from laboratories in clinical chemistry and clinical immunology in nine regions. 1104 samples total. These 9 regions include 7180898 out of Sweden's total population of 10327589	
Sweden	SWE1		65	95	J‰mtland, Jˆnkˆping, Kalmar, SkÂne, Stockholm, Uppsala, V‰sterbotten, V‰stra Gˆtaland and ÷rebro	both			0.027				deaths.csv	2020-04-27	2020-05-03	1	0	0	0	https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-for-covid-19-virus/ , accessed 31/05/2020	Blood samples are collected from laboratories in clinical chemistry and clinical immunology in nine regions. 1104 samples total. These 9 regions include 7180898 out of Sweden's total population of 10327589	
Sweden	SWE1		0	999	Skane	both			0.042				deaths.csv	2020-04-27	2020-05-03	0	0	1	0	https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-for-covid-19-virus/ , accessed 31/05/2020	Blood samples are collected from laboratories in clinical chemistry and clinical immunology in nine regions. 1104 samples total. These 9 regions include 7180898 out of Sweden's total population of 10327589	
Sweden	SWE1		0	999	Stockholm	both			0.073				deaths.csv	2020-04-27	2020-05-03	0	0	1	0	https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-for-covid-19-virus/ , accessed 31/05/2020	Blood samples are collected from laboratories in clinical chemistry and clinical immunology in nine regions. 1104 samples total. These 9 regions include 7180898 out of Sweden's total population of 10327589	
Sweden	SWE1		0	999	Vastra Gotaland	both			0.037				deaths.csv	2020-04-27	2020-05-03	0	0	1	0	https://www.folkhalsomyndigheten.se/nyheter-och-press/nyhetsarkiv/2020/maj/forsta-resultaten-fran-pagaende-undersokning-av-antikroppar-for-covid-19-virus/ , accessed 31/05/2020	Blood samples are collected from laboratories in clinical chemistry and clinical immunology in nine regions. 1104 samples total. These 9 regions include 7180898 out of Sweden's total population of 10327589	
United Kingdom	GBR2		17	70	East of England	both	1337	74	0.05534779357					2020-05-10	2020-06-08	0	0	1		PHE - private data		
United Kingdom	GBR2		17	70	London	both	1710	233	0.1362573099					2020-05-10	2020-06-08	0	0	1	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		17	70	Midlands	both	809	47	0.05809641533					2020-05-10	2020-06-08	0	0	1	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		17	70	North East and Yorkshire	both	1001	66	0.06593406593					2020-05-10	2020-06-08	0	0	1		PHE - private data		
United Kingdom	GBR2		17	70	North West	both	1018	83	0.0815324165					2020-05-10	2020-06-08	0	0	1	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		17	70	South East	both	1001	57	0.05694305694					2020-05-10	2020-06-08	0	0	1	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		17	70	South West	both	1102	41	0.03720508167					2020-05-10	2020-06-08	0	0	1	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		17	20	all	both	183	15	0.08241758					2020-05-10	2020-06-08	1	0	0	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		20	30	all	both	1354	155	0.11567164					2020-05-10	2020-06-08	1	0	0	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		30	40	all	both	1605	127	0.08022742					2020-05-10	2020-06-08	1	0	0	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		40	50	all	both	1689	112	0.06698565					2020-05-10	2020-06-08	1	0	0	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		50	60	all	both	1990	127	0.06440162					2020-05-10	2020-06-08	1	0	0	0	PHE - private data	will be updated over time - these are the latest month's data.	
United Kingdom	GBR2		60	70	all	both	1157	65	0.05657093					2020-05-10	2020-06-08	1	0	0	0	PHE - private data	will be updated over time - these are the latest month's data.	
USA	SF_CA1	0525_SanFrancisco	19	89	Sonoma, Marin, Napa, Solano, Contra Costa, Alameda, Santa Clara, San Mateo, Sacramento, San Joaquin counties	both	1000	4	0.004					2020-03-01	2020-03-31	0	0	0	1	https://www.medrxiv.org/content/10.1101/2020.05.19.20107482v2.full.pdf	dates given are 'march'	
Switzerland	CHE2	0622_Zurich	18	75	Zurich	both	1469	16	0.011					2020-04-01	2020-04-30	0	0	0	1	https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v2.full.pdf		
Switzerland	CHE2	0622_Zurich	18	75	Zurich	both	1640	26	0.016					2020-05-01	2020-05-31	0	0	0	1	https://www.medrxiv.org/content/10.1101/2020.05.31.20118554v2.full.pdf		
Brazil	BRA2	0629_SaoPaulo	18	999	Sao Paulo municipality	both	517	27	0.05222437137					2020-05-04	2020-05-12	0	0	0	??	https://www.medrxiv.org/content/10.1101/2020.06.29.20142331v1.full.pdf+html	has gender and age (< & > 45, but only adjusted seroprevalence, not raw seroprevalence). Also has distinction between IgM and IgG, not sure what we want to do with this?	
Brazil	BRA3	0616_Brazil	2	999	Espirito Santo State - Prevalence Study (multiple unidenfitied settlements in most populous municipalities)	both	4608	97	0.02105034722					2020-05-13	2020-05-15	1	1	0	??	https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1	prevalence study has sex and age breakdown, extension study does not	no details on specific parts of Espirito Santo included in prevalence vs extension study except that prevalence study was done in the most populous municipality for each of the 8 census regions, as well as a number of others in the metropolitan region and one miscellaneous, leading to 11 toaly. And the extension was done on 16 lesser populous municipalities, 2 in each region. 
Brazil	BRA3	0616_Brazil	2	999	Espirito Santo State - Extension Study (multiple unidentified settlements in less populous municipalities)	both	1163	3	0.002579535684					2020-05-13	2020-05-15	0	0	0	??	https://www.medrxiv.org/content/10.1101/2020.06.13.20130559v1	prevalence study has sex and age breakdown, extension study does not	no details on specific parts of Espirito Santo included in prevalence vs extension study except that prevalence study was done in the most populous municipality for each of the 8 census regions, as well as a number of others in the metropolitan region and one miscellaneous, leading to 11 toaly. And the extension was done on 16 lesser populous municipalities, 2 in each region. 
Brazil	BRA4	0706_RiodeJaneiro	18	69	Rio de Janeiro city	both	2857	114	0.0399019951					2020-04-14	2020-04-27	1	1	0	??	https://pmlegacy.ncbi.nlm.nih.gov/pubmed/32638883	Done in blood donors; also note, have both IgG and IgM disaggregated, but only as %s. Have to had to convert from percentage seropositive (unadjusted back to number positive, but fairly certain this is correct (given it's to 1DP, can only be 113, 114 or 115 positives))	
Brazil	BRA5	0708_RioGrande	0	999	Rio Grande do Sul state (cities = Uruguaiana, Ijui, Santa Maria, Passo Fundo, Santa Cruz do Sul, Pelotas, Caxias, Canoas and Porto Alegre)	both	4151	2	0.0004818116117					2020-04-11	2020-04-13	0	0	0	??	https://www.nature.com/articles/s41591-020-0992-3#Sec14	Contains information for each of the 9 cities in the Supplementary Information	
Brazil	BRA5	0708_RioGrande	0	999	Rio Grande do Sul state (cities = Uruguaiana, Ijui, Santa Maria, Passo Fundo, Santa Cruz do Sul, Pelotas, Caxias, Canoas and Porto Alegre)	both	4460	6	0.00134529148					2020-04-25	2020-04-27	0	0	0	??	https://www.nature.com/articles/s41591-020-0992-3#Sec14	Contains information for each of the 9 cities in the Supplementary Information	
Brazil	BRA5	0708_RioGrande	0	999	Rio Grande do Sul state (cities = Uruguaiana, Ijui, Santa Maria, Passo Fundo, Santa Cruz do Sul, Pelotas, Caxias, Canoas and Porto Alegre)	both	4500	10	0.002222222222					2020-05-09	2020-05-11	0	0	0	??	https://www.nature.com/articles/s41591-020-0992-3#Sec14	Contains information for each of the 9 cities in the Supplementary Information	
Italy	ITA1		0	17	all	both			0.022					2020-05-25	2020-07-15	1	0	0		https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf	total sample size	
Italy	ITA1		18	34	all	both			0.021					2020-05-25	2020-07-15	1	0	0		https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		35	49	all	both			0.024					2020-05-25	2020-07-15	1	0	0		https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		50	59	all	both			0.031					2020-05-25	2020-07-15	1	0	0		https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		60	69	all	both			0.026					2020-05-25	2020-07-15	1	0	0		https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		70	999	all	both			0.025					2020-05-25	2020-07-15	1	0	0		https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Piemonte	both			0.030051936					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Valle D'Aosta	both			0.040183284					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Liguria	both			0.031047951					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Lombardia	both			0.075297609					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Bolzano	both			0.032742223					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Trento	both			0.031484006					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Veneto	both			0.019169246					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Friuli-Venenzia Giulia	both			0.010407628					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Emilia-Romagna	both			0.028113503					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Toscana	both			0.0102572					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Umbria	both			0.008561149					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Marche	both			0.027420883					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Lazio	both			0.009599673					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Abruzzo	both			0.015265645					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Molise	both			0.006992453					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Campania	both			0.007365246					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Puglia	both			0.008890286					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Basilicata	both			0.007591805					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Clabria	both			0.005821159					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Sicilia	both			0.00334543					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Italy	ITA1		0	999	Sardegna	both			0.003310658					2020-05-25	2020-07-15	0	0	1	0	https://www.istat.it/it/files//2020/08/ReportPrimiRisultatiIndagineSiero.pdf		
Luxembourg	LUX1	0518_Luxembourg	18	79	all	both	1807	35				0.020947		2020-04-15	2020-05-05	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.05.11.20092916v1.full.pdf		
China	CHN1	0619_Wuhan	16	19	Wuhan	both	52	0				0		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	20	24	Wuhan	both	652	19				0.02975		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	25	29	Wuhan	both	2330	61				0.0262		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	30	34	Wuhan	both	3251	111				0.03403		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	35	39	Wuhan	both	2748	95				0.03465		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	40	44	Wuhan	both	2317	79				0.0342		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	45	49	Wuhan	both	2321	74				0.03185		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	50	54	Wuhan	both	2288	92				0.0402		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	55	59	Wuhan	both	1938	92				0.0475		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		
China	CHN1	0619_Wuhan	60	999	Wuhan	both	494	18				0.035535		2020-03-26	2020-04-28	1	0	0	0	https://www.medrxiv.org/content/10.1101/2020.06.16.20132423v2.supplementary-material		